Tiffany Mecham, an OCRA Advocate Leader, is using her platform as a contestant in the upcoming Mrs. Idaho pageant to raise awareness of ovarian cancer. In a segment with Sophia Doumani for KBOI CBS 2 Boise News, Tiffany talks about what motivates her to use her platform to accelerate progress against ovarian cancer. As an … Continued
OCRA’s Advocates Push for Critical Legislative Action at Spring Advocacy Day More than 140 advocates, representing 37 states and 107 congressional districts, met virtually with nearly 180 congressional offices last week to request increased federal funding around vital ovarian and related gynecologic cancer programs. Chad Ramsey, OCRA’s Vice President of Policy, takes you behind the … Continued
OCRA’s four Collaborative Research Development Grants, including a partnership grant through Microsoft AI for Health, are multi-investigator studies set to tackle the most pressing issues in research, treatment and care. “In an all-around stellar crop of new OCRA-funded research for 2024, our collaborative studies hold particular promise,” says Audra Moran, OCRA’s President & CEO. “By … Continued
Chef Elle Simone Scott, dedicated board member of Ovarian Cancer Research Alliance (OCRA) and renowned figure in the culinary world through America’s Test Kitchen and more, is raising crucial awareness about ovarian cancer, as shared in a San Francisco Bay Times article “Coming Out for Women’s Health”. Diagnosed with ovarian cancer in 2016, Elle is … Continued
OCRA Harnessing Artificial Intelligence to Develop Blood Test to Detect Ovarian Cancer In a news segment for NBC 4 New York, Dr. Daniel Heller, an OCRA grantee, discussed the exciting OCRA-funded study being undertaken in partnership with Microsoft AI for Health. “We’re really excited about the power of AI because there has been so much success in … Continued
Research breakthroughs are around the corner. In 2023, OCRA announced $9.2 million in research initiatives for 2024 — the largest in our history — including awarding 20 grants to scientists at 15 prestigious institutions. Recommended for funding by OCRA’s Scientific Advisory Committee from a competitive evaluation process, these exceptional researchers and their forward-thinking studies will tackle … Continued
An OCRA research team is using Artificial Intelligence (AI) to develop a blood test to potentially detect ovarian cancer, as part of an OCRA-funded study in partnership with Microsoft AI for Good Lab. OCRA grantee Daniel Heller, PhD, lead researcher at The Daniel Heller Lab at Memorial Sloan Kettering Cancer Center discusses this cutting-edge technology … Continued
Ovarian Cancer Research Alliance is pleased to welcome our 2024 cohort of Advocate Leaders, the biggest ever for our organization with a total of 125 participants. This year’s group, which comprises 43 new participants and 82 returnees, represents 39 states, including the new additions of Nevada and North Dakota. “We are so excited to get … Continued
Newly Redesigned YouTube Channel and Video From OCRA CEO Watch a new video from OCRA’s President & CEO Audra Moran, and find videos with patient resources, treatment and research updates, ways to get involved with OCRA, words of encouragement from celebrity friends and more, on OCRA’s redesigned YouTube channel. OCRA’s Advocate’s Corner Monthly Series What’s happening on Capitol … Continued
In this new video, hear from Audra Moran, OCRA’s President and CEO, about some of the many ways we offer community and support to ovarian and gynecologic cancer patients — and how we are expediting progress toward a cure. For more videos about our patient resources, as well as treatment and research updates, ways to get … Continued
Ovarian Cancer Research Alliance (OCRA), the world’s largest ovarian cancer charity, announced today the 2023 winners of the Rosalind Franklin Prize for Excellence in Ovarian Cancer Research and the Schreiber Research Prize for Outstanding Mentored Investigators. One recipient is being recognized for her noteworthy leadership in the field, which includes seminal work in novel therapeutics … Continued
[New York, NY January 17, 2024] – Ovarian Cancer Research Alliance (OCRA) proudly announces the successful culmination of an extraordinary year, marking 2023 as a milestone in our pursuit of advancing knowledge, treatment, and support for individuals impacted by ovarian and related gynecologic cancers. Underscoring a testament to the collective commitment to defeating these diseases, … Continued
Get email updates about research news, action alerts, and ways to join the fight.
